Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Journey medical corp source : Www.vynetherapeutics.com save search
VYNE Therapeutics Reports Year-End 2022 Financial Results and Provides Business Update
Published: 2023-03-09 (Crawled : 23:00) - vynetherapeutics.com
DERM | $3.4 -3.96% -3.36% 60K
|
|
| O: -3.33%
H: 6.9%
C: 3.45%
VYNE | $2.57 10.78% 12.45% 380K
|
Health Technology
|
| O: -1.31%
H: 1.32%
C: -0.66%
therapeutics financial update results
VYNE Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-12 (Crawled : 22:00) - vynetherapeutics.com
DERM | $3.4 -3.96% -3.36% 60K
|
|
| O: 0.0%
H: 5.79%
C: 4.27%
VYNE | $2.57 10.78% 12.45% 380K
|
Health Technology
|
| O: -2.45%
H: 8.11%
C: 0.32%
therapeutics results
VYNE Therapeutics Reports Year-End 2021 Financial Results and Provides Corporate Update
Published: 2022-03-17 (Crawled : 12:30) - vynetherapeutics.com
DERM | $3.4 -3.96% -3.36% 60K
|
|
| O: 1.76%
H: 4.32%
C: -2.81%
VYNE | $2.57 10.78% 12.45% 380K
|
Health Technology
|
| O: 0.0%
H: 8.8%
C: 6.09%
financial results therapeutics report results
VYNE Therapeutics Divests Topical Minocycline Assets
Published: 2022-01-13 (Crawled : 12:30) - vynetherapeutics.com
DERM | $3.4 -3.96% -3.36% 60K
|
|
| O: -6.49%
H: 7.54%
C: 2.78%
VYNE | $2.57 10.78% 12.45% 380K
|
Health Technology
|
| O: 2.86%
H: 0.93%
C: -27.27%
therapeutics
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
MTH | $154.69 -2.21% 7.56% 64
|
Consumer Durables
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
IHT P | $1.3712 0.82% 6.48% 0
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.